Annual EBITDA
Summary
- Current Value
- As of today, GILD annual EBITDA is $14.58B, up +8.60% on
- Historical Performance
- GILD annual EBITDA is up +13.39% over the past 3 years, up +22.29% over the past 5 years
- All-Time High Comparison
- GILD annual EBITDA is currently -35.73% below its historical high of $22.69B set on
- 3-Year Low Comparison
- GILD annual EBITDA is +17.25% above its 3-year low of $12.44B reached on
- Sector Comparison
- GILD annual EBITDA is higher than 98.80% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $14.58B | +8.6% | +13.4% | +22.3% | +248.9% | |
| Quarterly EBITDA | $3.66B | +14.3% | +10.9% | +4.2% | +301.8% | |
| TTM EBITDA | $14.56B | +8.4% | +9.6% | +25.3% | +248.4% | |
| Price | $143.90 | +24.6% | +77.5% | +122.7% | +607.0% | |
| PE Ratio | 21.22 | -93.3% | -4.8% | -97.4% | +72.5% | |
| Annual Revenue | $29.45B | +2.5% | +8.7% | +19.5% | +273.9% | |
| Annual EPS | $6.78 | +1672.8% | +86.4% | +6861.9% | +308.3% | |
| Annual EBIT | $11.82B | +10.8% | +9.8% | +13.2% | +201.9% | |
| Annual Net Income | $8.51B | +1672.9% | +86.4% | +9461.8% | +194.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $14.58B | at high | |
| 5Y | $14.58B | at high | |
| All | $22.69B | -35.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $12.44B | +17.3% | |
| 5Y | $11.92B | N/A | +22.3% |
| All | -$104.60M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of GILD?
As of today, GILD annual EBITDA is $14.58B
What is 1-year change in GILD annual EBITDA?
GILD annual EBITDA is up +8.60% year-over-year
What is 3-year change in GILD annual EBITDA?
GILD annual EBITDA is up +13.39% over the past 3 years
How far is GILD annual EBITDA from its all-time high?
GILD annual EBITDA is currently -35.73% below its historical high of $22.69B set on December 31, 2015
How does GILD annual EBITDA rank versus sector peers?
GILD annual EBITDA is higher than 98.80% of companies in Healthcare sector
When is GILD next annual earnings release?
As of today, the next annual earnings release for GILD has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, GILD quarterly EBITDA is $3.66B, down -13.17% on
- Historical Performance
- GILD quarterly EBITDA is up +14.30% year-over-year, up +10.91% over the past 3 years
- All-Time High Comparison
- GILD quarterly EBITDA is currently -36.56% below its historical high of $5.77B set on
- 3-Year Low Comparison
- GILD quarterly EBITDA is +41.86% above its 3-year low of $2.58B reached on
- Sector Comparison
- GILD quarterly EBITDA is higher than 98.99% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $3.66B | -13.2% | +14.3% | +10.9% | +4.2% | |
| Annual EBITDA | $14.58B | – | +8.6% | +13.4% | +22.3% | |
| TTM EBITDA | $14.56B | +3.3% | +8.4% | +9.6% | +25.3% | |
| Price | $143.90 | +18.7% | +24.6% | +77.5% | +122.7% | |
| PE Ratio | 21.22 | +13.0% | -93.3% | -4.8% | -97.4% | |
| Quarterly Revenue | $7.96B | +2.2% | +5.2% | +8.8% | +7.0% | |
| Quarterly EPS | $1.74 | -28.4% | +23.0% | +34.3% | +41.4% | |
| Quarterly EBIT | $2.96B | -16.0% | +18.1% | +6.9% | -3.9% | |
| Quarterly Net Income | $2.18B | -28.5% | +22.4% | +33.7% | +41.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.22B | -13.2% | |
| 3Y | $4.22B | -13.2% | |
| 5Y | $4.36B | -16.1% | |
| All | $5.77B | -36.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.20B | N/A | +14.3% |
| 3Y | $2.58B | +41.9% | |
| 5Y | $2.00B | +83.2% | |
| All | -$1.16B | +416.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GILD?
As of today, GILD quarterly EBITDA is $3.66B
What is GILD quarterly EBITDA most recent change?
GILD quarterly EBITDA was down -13.17% on December 31, 2025
What is 1-year change in GILD quarterly EBITDA?
GILD quarterly EBITDA is up +14.30% year-over-year
How far is GILD quarterly EBITDA from its all-time high?
GILD quarterly EBITDA is currently -36.56% below its historical high of $5.77B set on June 30, 2015
How does GILD quarterly EBITDA rank versus sector peers?
GILD quarterly EBITDA is higher than 98.99% of companies in Healthcare sector
When is GILD next earnings release?
The next earnings release for GILD is on
TTM EBITDA
Summary
- Current Value
- As of today, GILD TTM EBITDA is $14.56B, up +3.25% on
- Historical Performance
- GILD TTM EBITDA is up +8.44% year-over-year, up +9.64% over the past 3 years
- All-Time High Comparison
- GILD TTM EBITDA is currently -36.01% below its historical high of $22.76B set on
- 3-Year Low Comparison
- GILD TTM EBITDA is +22.56% above its 3-year low of $11.88B reached on
- Sector Comparison
- GILD TTM EBITDA is higher than 98.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $14.56B | +3.3% | +8.4% | +9.6% | +25.3% | |
| Annual EBITDA | $14.58B | – | +8.6% | +13.4% | +22.3% | |
| Quarterly EBITDA | $3.66B | -13.2% | +14.3% | +10.9% | +4.2% | |
| Price | $143.90 | +18.7% | +24.6% | +77.5% | +122.7% | |
| PE Ratio | 21.22 | +13.0% | -93.3% | -4.8% | -97.4% | |
| TTM Revenue | $29.45B | +1.4% | +2.5% | +8.7% | +19.5% | |
| TTM EPS | $6.78 | +5.0% | +1747.0% | +86.4% | +8584.1% | |
| TTM EBIT | $11.79B | +4.0% | +10.6% | +5.5% | +16.3% | |
| TTM Net Income | $8.51B | +4.9% | +1672.9% | +86.4% | +9461.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $14.56B | at high | |
| 3Y | $14.56B | at high | |
| 5Y | $14.56B | at high | |
| All | $22.76B | -36.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $13.43B | N/A | +8.4% |
| 3Y | $11.88B | +22.6% | |
| 5Y | $11.62B | N/A | +25.3% |
| All | -$104.60M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GILD?
As of today, GILD TTM EBITDA is $14.56B
What is GILD TTM EBITDA most recent change?
GILD TTM EBITDA was up +3.25% on December 31, 2025
What is 1-year change in GILD TTM EBITDA?
GILD TTM EBITDA is up +8.44% year-over-year
How far is GILD TTM EBITDA from its all-time high?
GILD TTM EBITDA is currently -36.01% below its historical high of $22.76B set on December 31, 2015
How does GILD TTM EBITDA rank versus sector peers?
GILD TTM EBITDA is higher than 98.90% of companies in Healthcare sector
When is GILD next earnings release?
The next earnings release for GILD is on
EBITDA Formula
Data Sources & References
- GILD Official Website www.gilead.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
- GILD Profile on Yahoo Finance finance.yahoo.com/quote/GILD
- GILD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gild
